Exhibit 99.1 Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance Revenue and Adjusted EBITDA results delivered in line with stated full-year targets Full ‑ year cost savings exceeded previously communicated targets Highlights: DURHAM, N.C., February 26, 2026 — Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization (CRO), today reported financial results for the fourth quarter and full year ended December 31, 2025. "We finished 2025 with ...

Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results Exhibit 99.1 ARLINGTON, VA – February 26, 2026 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Each of the Company's operating and financial performance metrics were at or above the high end of its guidance ranges for 2025, as highlighted below. Full-Year Performance | | | | For the Years Ended December 31, | | | | --- | --- | --- ...

Exhibit 99.1 BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership SAN CARLOS, Calif. – February 26, 2026 – BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the fourth quarter and full year 2025. "These strong financial results for the fourth quarter and full year 2025 underscore our continued evolution as a ...

Exhibit 99.1 "These strong financial results for the fourth quarter and full year 2025 underscore our continued evolution as a global oncology leader with durable competitive advantages in clinical development and manufacturing and one of the industry's deepest and most differentiated pipelines," said John V. Oyler, Co-Founder, Chairman and CEO at BeOne. "BRUKINSA has firmly established itself as the global leader in the BTK inhibitor class, distinguished by broad regulatory approvals, expanding geographic ...

Ecovyst Fourth Quarter and Year 2025 Earnings Release Page 1 • Completed sale of Advanced Materials & Catalysts segment to Technip Energies N.V. for a sale price of $556 million. • Sales of $199.4 million, compared to $148.9 million in the fourth quarter of 2024 • Net income of $9.2 million compared to $23.8 million in the fourth quarter of 2024, with a net income margin of 4.6% and with diluted net income per share of $0.08 • Adjusted Net Income of $32.4 million, compared to $18.4 million in the fourth qua ...

Celsius Holdings Reports Full-Year 2025 and Fourth Quarter Financial Results Record annual revenue of $2.5 billion reflects scale and disciplined growth in fast-growing energy category Strategic energy leadership and portfolio integration within PepsiCo system positions company for sustainable growth Celsius Holdings' portfolio contributed 33% of the zero-sugar l U.S. energy category's $3.3 billion growth in 2025 1 BOCA RATON, Fla., Feb. 26, 2026 — Celsius Holdings, Inc. (Nasdaq: CELH) ("Celsius Holdings" o ...

Exhibit 99.1 Acushnet Holdings Corp. Announces Full Year and Fourth Quarter 2025 Financial Results, Declares Increased Quarterly Cash Dividend, Introduces 2026 Outlook Key Highlights: FAIRHAVEN, MA – February 26, 2026 – Acushnet Holdings Corp. (NYSE: GOLF) ("Acushnet" or the "Company"), the global leader in the design, development, manufacture and distribution of performance-driven golf products, today reported financial results for the full year and fourth quarter ended December 31, 2025. "Acushnet achieve ...

EXHIBIT 99.1 Contact: Kristen Griffith Investor Relations IR@nexpoint.com Media: pro-nexpoint@prosek.com NREF Announces Fourth Quarter 2025 Results, Provides First Quarter 2026 Guidance Dallas, TX, Thursday, February 26, 2026 – NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended December 31, 2025. NREF reported net income attributable to common stockholders of $13.6 million, or 0.52 per diluted share 1 , for the three months en ...

Exhibit 99.1 First Advantage Reports Fourth Quarter and Full Year 2025 Results Delivers Outstanding Fourth Quarter Results and Issues Full Year 2026 Guidance Fourth Quarter 2025 Highlights 1 Full Year 2025 Highlights 1 Full Year 2026 Guidance • Introducing full year 2026 guidance ranges for Revenues of $1,625 million to $1,700 million, Adjusted EBITDA of $460 million to $485 million, Adjusted Net Income of $200 million to $220 million, and Adjusted Diluted Earnings Per Share of $1.15 to $1.25 3 ATLANTA, Feb ...

Exhibit 99.1 Walker & Dunlop Reports Fourth Quarter 2025 Financial Results FOURTH QUARTER 2025 HIGHLIGHTS FULL-YEAR 2025 HIGHLIGHTS BETHESDA, MD – FEBRUARY 26, 2026 – Walker & Dunlop, Inc. (NYSE: WD) (the "Company", "Walker & Dunlop" or "W&D") reported fourth quarter results that reflect significant improvement in its core Capital Markets business, which delivered a 36% increase in total transaction volume to $18.3 billion year over year, and generated fourth quarter revenues of $340 million. The Company re ...